We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blockers did not improve clinical outcomes after ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...

Please provide your email address to receive an email when new articles are posted on . PARIS — Beta-blockers reduced mortality in patients with sinus rhythm and HF with reduced ejection fraction, ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Beta-blockers have had a 40-year reign as the standard treatment for heart attack patients. That may come to an end, based on the results of two new studies. What’s more, women who take beta-blockers ...

The study covered in this summary was published on ResearchSquare.com as a preprint and has not yet been peer reviewed. ANT and TZB are both effective in the treatment of breast cancer but can be ...

PARIS, France—Even when facing moderately-severe renal impairment, patients who have heart failure with reduced ejection fraction (HFrEF) and are in sinus rhythm can derive a survival benefit from ...

A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood pressure, did not provide clear benefits for heart attack patients ...